BUONDONNO, ILARIA
BUONDONNO, ILARIA
SCIENZE MEDICHE
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells
2015-01-01 Campia, Ivana; Buondonno, Ilaria; Castella, Barbara; Rolando, Barbara; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara
ANABOLIC THERAPY WITH PTH 1-84 INFLUENCES ENERGY AND GLUCOSE METABOLISM
2012-01-01 Patrizia D’Amelio; Cristina Tamone; Elena Spertino; Simonetta Piano; Francesca Sassi; Ilaria Buondonno; Giovanni Carlo Isaia
Association between Immunosenescence, Mitochondrial Dysfunction and Frailty Syndrome in Older Adults
2023-01-01 Buondonno, Ilaria; Sassi, Francesca; Cattaneo, Francesco; D’Amelio, Patrizia
Effect of intermittent PTH treatment on plasma glucose in osteoporosis: A randomized trial.
2015-01-01 D'Amelio P;Sassi F;Buondonno I;Spertino E;Tamone C;Piano S;Zugna D;Richiardi L;Isaia GC
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma
2019-01-01 Buondonno, Ilaria; Gazzano, Elena; Tavanti, Elisa; Chegaev, Konstantin; Kopecka, Joanna; Fanelli, Marilù; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto; Hattinger, Claudia; Serra, Massimo; Riganti, Chiara*
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin.
2015-01-01 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors
2018-01-01 Gazzano, Elena; Rolando, Barbara; Chegaev, Konstantin; Salaroglio, Iris C.; Kopecka, Joanna; Pedrini, Isabella; Saponara, Simona; Sorge, Matteo; Buondonno, Ilaria; Stella, Barbara; Marengo, Alessandro; Valoti, Massimo; Brancaccio, Mara; Fruttero, Roberta; Gasco, Alberto; Arpicco, Silvia; Riganti, Chiara
From mitochondria to healthy aging: The role of branched-chain amino acids treatment: MATeR a randomized study
2019-01-01 Buondonno I.; Sassi F.; Carignano G.; Dutto F.; Ferreri C.; Pili F.G.; Massaia M.; Nisoli E.; Ruocco C.; Porrino P.; Ravetta C.; Riganti C.; Isaia G.C.; D'Amelio P.
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance
2016-01-01 Chegaev, Konstantin; Rolando, Barbara; Cortese, Daniela; Gazzano, Elena; Buondonno, Ilaria; Lazzarato, Loretta; Fanelli, Marilù; Hattinger, Claudia M; Serra, Massimo; Riganti, Chiara; Fruttero, Roberta; Ghigo, Dario; Gasco, Alberto
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts
2019-01-01 Gazzano E.; Buondonno I.; Marengo A.; Rolando B.; Chegaev K.; Kopecka J.; Saponara S.; Sorge M.; Hattinger C.M.; Gasco A.; Fruttero R.; Brancaccio M.; Serra M.; Stella B.; Fattal E.; Arpicco S.; Riganti C.
IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice
2015-01-01 Li, Jau-Yi; D'Amelio, Patrizia; Robinson, Jerid; Walker, Lindsey D; Vaccaro, Chiara; Luo, Tao; Tyagi, Abdul Malik; Yu, Mingcan; Reott, Michael; Sassi, Francesca; Buondonno, Ilaria; Adams, Jonathan; Weitzmann, M Neale; Isaia, Giovanni Carlo; Pacifici, Roberto
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
2016-01-01 Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara
Musculoskeletal Diseases Role in the Frailty Syndrome: A Case–Control Study
2022-01-01 Francesco Cattaneo; Ilaria Buondonno; Debora Cravero; Francesca Sassi; Patrizia D’Amelio
New pharmacological tools against doxorubicin-resistant osteosarcomas targeting mitochondria and endoplasmic reticulum of resistant cells
2018-03-12
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy
2017-01-01 Salaroglio, Iris C; Panada, Elisa; Moiso, Enrico; Buondonno, Ilaria; Provero, Paolo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara
PTH treatment induces WNT10b expression in humans lymphoid cells
2014-01-01 Patrizia D'Amelio; Francesca Sassi; Ilaria Buondonno; Elena Spertino; Lucia D'Amico; Ilaria Roato; Giovanni Carlo Isaia
Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice
2018-01-01 Yu, Mingcan; D'Amelio, Patrizia; Tyagi, Abdul Malik; Vaccaro, Chiara; Li, Jau-Yi; Hsu, Emory; Buondonno, Ilaria; Sassi, Francesca; Adams, Jonathan; Weitzmann, M Neale; DiPaolo, Richard; Pacifici, Roberto
Role of estrogen replacement therapy in the control of immune system in postmenopausal osteoporosis.
2013-01-01 P. D’Amelio; F. Sassi; I. Buondonno; G. Fornelli; E. Bonardo; G.C. Isaia.
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
2015-01-01 Rigoni, Micol; Riganti, Chiara; Vitale, Candida; Griggio, Valentina; Campia, Ivana; Robino, Marta; Foglietta, Myriam; Castella, Barbara; Sciancalepore, Patrizia; Buondonno, Ilaria; Drandi, Daniela; Ladetto, Marco; Boccadoro, Mario; Massaia, Massimo; Coscia, Marta
Small nucleolar RNAs determine resistance to doxorubicin in human osteosarcoma
2020-01-01 Godel M.; Morena D.; Ananthanarayanan P.; Buondonno I.; Ferrero G.; Hattinger C.M.; Di Nicolantonio F.; Serra M.; Taulli R.; Cordero F.; Riganti C.; Kopecka J.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells | 2015 | Campia, Ivana; Buondonno, Ilaria; Castella, Barbara; Rolando, Barbara; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara | |
ANABOLIC THERAPY WITH PTH 1-84 INFLUENCES ENERGY AND GLUCOSE METABOLISM | 2012 | Patrizia D’Amelio; Cristina Tamone; Elena Spertino; Simonetta Piano; Francesca Sassi; Ilaria Buondonno; Giovanni Carlo Isaia | |
Association between Immunosenescence, Mitochondrial Dysfunction and Frailty Syndrome in Older Adults | 2023 | Buondonno, Ilaria; Sassi, Francesca; Cattaneo, Francesco; D’Amelio, Patrizia | |
Effect of intermittent PTH treatment on plasma glucose in osteoporosis: A randomized trial. | 2015 | D'Amelio P;Sassi F;Buondonno I;Spertino E;Tamone C;Piano S;Zugna D;Richiardi L;Isaia GC | |
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma | 2019 | Buondonno, Ilaria; Gazzano, Elena; Tavanti, Elisa; Chegaev, Konstantin; Kopecka, Joanna; Fanelli, Marilù; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto; Hattinger, Claudia; Serra, Massimo; Riganti, Chiara* | |
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. | 2015 | Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S. | |
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors | 2018 | Gazzano, Elena; Rolando, Barbara; Chegaev, Konstantin; Salaroglio, Iris C.; Kopecka, Joanna; Pedrini, Isabella; Saponara, Simona; Sorge, Matteo; Buondonno, Ilaria; Stella, Barbara; Marengo, Alessandro; Valoti, Massimo; Brancaccio, Mara; Fruttero, Roberta; Gasco, Alberto; Arpicco, Silvia; Riganti, Chiara | |
From mitochondria to healthy aging: The role of branched-chain amino acids treatment: MATeR a randomized study | 2019 | Buondonno I.; Sassi F.; Carignano G.; Dutto F.; Ferreri C.; Pili F.G.; Massaia M.; Nisoli E.; Ruocco C.; Porrino P.; Ravetta C.; Riganti C.; Isaia G.C.; D'Amelio P. | |
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance | 2016 | Chegaev, Konstantin; Rolando, Barbara; Cortese, Daniela; Gazzano, Elena; Buondonno, Ilaria; Lazzarato, Loretta; Fanelli, Marilù; Hattinger, Claudia M; Serra, Massimo; Riganti, Chiara; Fruttero, Roberta; Ghigo, Dario; Gasco, Alberto | |
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts | 2019 | Gazzano E.; Buondonno I.; Marengo A.; Rolando B.; Chegaev K.; Kopecka J.; Saponara S.; Sorge M.; Hattinger C.M.; Gasco A.; Fruttero R.; Brancaccio M.; Serra M.; Stella B.; Fattal E.; Arpicco S.; Riganti C. | |
IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice | 2015 | Li, Jau-Yi; D'Amelio, Patrizia; Robinson, Jerid; Walker, Lindsey D; Vaccaro, Chiara; Luo, Tao; Tyagi, Abdul Malik; Yu, Mingcan; Reott, Michael; Sassi, Francesca; Buondonno, Ilaria; Adams, Jonathan; Weitzmann, M Neale; Isaia, Giovanni Carlo; Pacifici, Roberto | |
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma | 2016 | Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara | |
Musculoskeletal Diseases Role in the Frailty Syndrome: A Case–Control Study | 2022 | Francesco Cattaneo; Ilaria Buondonno; Debora Cravero; Francesca Sassi; Patrizia D’Amelio | |
New pharmacological tools against doxorubicin-resistant osteosarcomas targeting mitochondria and endoplasmic reticulum of resistant cells | 2018 | - | |
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy | 2017 | Salaroglio, Iris C; Panada, Elisa; Moiso, Enrico; Buondonno, Ilaria; Provero, Paolo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara | |
PTH treatment induces WNT10b expression in humans lymphoid cells | 2014 | Patrizia D'Amelio; Francesca Sassi; Ilaria Buondonno; Elena Spertino; Lucia D'Amico; Ilaria Roato; Giovanni Carlo Isaia | |
Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice | 2018 | Yu, Mingcan; D'Amelio, Patrizia; Tyagi, Abdul Malik; Vaccaro, Chiara; Li, Jau-Yi; Hsu, Emory; Buondonno, Ilaria; Sassi, Francesca; Adams, Jonathan; Weitzmann, M Neale; DiPaolo, Richard; Pacifici, Roberto | |
Role of estrogen replacement therapy in the control of immune system in postmenopausal osteoporosis. | 2013 | P. D’Amelio; F. Sassi; I. Buondonno; G. Fornelli; E. Bonardo; G.C. Isaia. | |
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells | 2015 | Rigoni, Micol; Riganti, Chiara; Vitale, Candida; Griggio, Valentina; Campia, Ivana; Robino, Marta; Foglietta, Myriam; Castella, Barbara; Sciancalepore, Patrizia; Buondonno, Ilaria; Drandi, Daniela; Ladetto, Marco; Boccadoro, Mario; Massaia, Massimo; Coscia, Marta | |
Small nucleolar RNAs determine resistance to doxorubicin in human osteosarcoma | 2020 | Godel M.; Morena D.; Ananthanarayanan P.; Buondonno I.; Ferrero G.; Hattinger C.M.; Di Nicolantonio F.; Serra M.; Taulli R.; Cordero F.; Riganti C.; Kopecka J. |